Table 4.

Comparison of treatment in the nodal and nonnodal groups


Treatment details

Nodal group

Nonnodal group
Patients never treated (%)   1 (2)   9 (24)  
Patients with treatment delay (%)   1 (2)   9 (24)  
    Treatment delay, mo (range)   24   Mean, 29 (8-175)  
Splenectomy (%)   8 (19)   9 (24)  
Combination chemotherapy (%) CHOP/other   20 (47)/11 (25)   13 (35)/3 (8)  
Autologous stem cell transplantation (%)   11 (26)   3 (8)  
Patients receiving 3 or more treatment regimens (%)
 
19 (44)
 
7 (19)
 

Treatment details

Nodal group

Nonnodal group
Patients never treated (%)   1 (2)   9 (24)  
Patients with treatment delay (%)   1 (2)   9 (24)  
    Treatment delay, mo (range)   24   Mean, 29 (8-175)  
Splenectomy (%)   8 (19)   9 (24)  
Combination chemotherapy (%) CHOP/other   20 (47)/11 (25)   13 (35)/3 (8)  
Autologous stem cell transplantation (%)   11 (26)   3 (8)  
Patients receiving 3 or more treatment regimens (%)
 
19 (44)
 
7 (19)
 

or Create an Account

Close Modal
Close Modal